期刊
MULTIPLE SCLEROSIS JOURNAL
卷 12, 期 5, 页码 646-651出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458506070947
关键词
addiction; cannabis; multiple sclerosis; pain; spasticity
Introduction Little is known about the extent and patterns of cannabis use in people with multiple sclerosis (MS). Methods MS patients attending neurology outpatient clinics at two hospitals in London and one in Kent, UK completed a questionnaire. Results Questionnaires were completed by 254/337 (75%) MS patients. Forty-three per cent had used cannabis at some stage (ever users). Of these, 68% (75/110) had used cannabis to alleviate symptoms of MS (MS-related cannabis use). Forty-six (18%) had used cannabis in the last month (current users), of whom 12% (31/254) had used it for symptom relief. Being married or having a long-term partner, tobacco smokers and increasing disability were independent risk factors for MS-related cannabis use. Compared to patients who could walk unaided, cannabis use was more likely in those who were chair-bound (adjusted OR 2.47; 1.10-5.56) or only able to walk with an aid (adjusted OR 1.56; 0.90-3.60). Pain and spasms were common reasons for cannabis use. Seventy-one per cent of individuals who had never used cannabis said they would try the drug if it were available on prescription. Conclusion A large proportion of MS patients had tried cannabis for symptom control, however current use was small. A subgroup with greater disability appears to derive some symptomatic benefit.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据